BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28941798)

  • 1. Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay.
    Tang S; Chen A; Zhou X; Zeng L; Liu M; Wang X
    Toxicol Lett; 2017 Nov; 281():74-83. PubMed ID: 28941798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the inhibition potential of plumbagin against cytochrome P450 using LC-MS/MS and cocktail approach.
    Chen A; Zhou X; Tang S; Liu M; Wang X
    Sci Rep; 2016 Jun; 6():28482. PubMed ID: 27329697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes.
    Lou D; Bao SS; Li YH; Lin QM; Yang SF; He JY
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):611-618. PubMed ID: 30825074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the inhibition risk of shikonin on human and rat UDP-glucuronosyltransferases (UGT) through the cocktail approach.
    Cheng Y; Tang S; Chen A; Zhang Y; Liu M; Wang X
    Toxicol Lett; 2019 Sep; 312():214-221. PubMed ID: 31128210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the inhibition effects of apatinib on human and rat cytochrome P450.
    Bao SS; Wen J; Zheng X; Zhou Q; Qu GE; Chen MJ; Hu GX
    Toxicol Lett; 2018 Nov; 297():1-7. PubMed ID: 30138636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH; Kwon MJ; Choi EJ; Zheng YF; Yoon KD; Liu KH; Bae SK
    Chem Biol Interact; 2013 Sep; 205(1):11-9. PubMed ID: 23777987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the inhibition risk of paris saponins, bioactive compounds from Paris polyphylla, on CYP and UGT enzymes via cocktail inhibition assays.
    Luo H; Xu Y; Sun D; Cheng Y; Sun Z; Gao J; Zhang Y; Wang X
    Regul Toxicol Pharmacol; 2020 Jun; 113():104637. PubMed ID: 32145316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of cytochrome P450 inhibitory properties of deoxyshikonin, a bioactive compound from Lithospermum erythrorhizon Sieb. et Zucc.
    Zhang Y; Gao J; Xu Y; Liu J; Huang S; Li G; Yao B; Sun Z; Wang X
    Phytother Res; 2022 Nov; ():. PubMed ID: 36317387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
    Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
    Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of acacetin inhibition potential against cytochrome P450 in vitro and in vivo.
    Zhou Y; Tu Y; Zhou Q; Hua A; Geng P; Chen F; Han A; Liu J; Dai D; Wang S; Wang J; Wen C
    Chem Biol Interact; 2020 Sep; 329():109147. PubMed ID: 32738202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of the inhibition of hydroxygenkwanin on human and rat cytochrome P450 by cocktail method.
    Gao J; Zhang Y; Lei X; Xu Y; Sun Z; Wang X
    Toxicol In Vitro; 2022 Mar; 79():105281. PubMed ID: 34843882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Micuda S; Mundlova L; Anzenbacherova E; Anzenbacher P; Chladek J; Fuksa L; Martinkova J
    Eur J Clin Pharmacol; 2004 Oct; 60(8):583-9. PubMed ID: 15378224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of cedrol, β-cedrene, and thujopsene on cytochrome P450 enzyme activities in human liver microsomes.
    Jeong HU; Kwon SS; Kong TY; Kim JH; Lee HS
    J Toxicol Environ Health A; 2014; 77(22-24):1522-32. PubMed ID: 25343299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
    Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
    Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
    Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity.
    Sun M; Tang Y; Ding T; Liu M; Wang X
    Fitoterapia; 2014 Jan; 92():1-8. PubMed ID: 24144799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide.
    Pekthong D; Martin H; Abadie C; Bonet A; Heyd B; Mantion G; Richert L
    J Ethnopharmacol; 2008 Feb; 115(3):432-40. PubMed ID: 18053665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of cytochrome P450 inhibitory properties of maslinic acid, a bioactive compound from Olea europaea L., and its structure-activity relationship.
    Sun M; Tang Y; Ding T; Liu M; Wang X
    Phytomedicine; 2015 Jan; 22(1):56-65. PubMed ID: 25636872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.